文献速递咽喉与嗓音

难治性慢性咳嗽:面向耳鼻咽喉科医师的最新综述

Refractory Chronic Cough: A State-of-the-Art Review for Otolaryngologists.
PubMed 文献 · Otolaryngol Head Neck Surg · 2024-11-22

本文为面向耳鼻咽喉科医师的最新综述,检索PubMed中关于慢性咳嗽尤其难治性慢性咳嗽的文献,总结病理生理新认识与新兴治疗手段。综述指出,针对咳嗽高敏反射的感觉输入或运动输出的神经调节剂、喉上神经阻滞、声带填充、肉毒毒素注射、局部辣椒素及未来可能的P2X3拮抗剂等新疗法正在发展,改善喉咽反流的诊治及行为性咳嗽抑制治疗也可能获益。

要点

  • 难治性慢性咳嗽患者在一线治疗胃食管反流、鼻窦疾病、肺部疾病及血管紧张素转化酶抑制剂相关咳嗽后需进一步评估。
  • 新兴治疗主要针对咳嗽高敏反射,包括神经调节剂、喉上神经阻滞、声带填充、肉毒毒素注射、局部辣椒素及P2X3拮抗剂。
  • 改善喉咽反流诊断与管理及行为性咳嗽抑制治疗可能使患者获益。

核心结论

  • 对难治性咳嗽生理的更深入理解促使多种新治疗选择出现,主要旨在阻断咳嗽高敏反射的感觉输入或改变运动活动。

研究设计与样本

  • 本文为最新综述,检索PubMed中关于慢性咳嗽(重点为难治性慢性咳嗽)、病理生理新范式及治疗进展的现有文献并进行总结。

主要发现

  • 新兴治疗包括神经调节剂、喉上神经阻滞、声带填充、肉毒毒素注射、局部辣椒素以及未来可能使用的P2X3拮抗剂。
  • 改善喉咽反流的诊断与管理以及行为性咳嗽抑制治疗的潜在获益也在讨论之列。

临床怎么用

  • 支持上述各策略的文献正在增多,随着更多难治性慢性咳嗽患者寻求耳鼻咽喉科诊治,了解这些方法可能改善该病的整体治疗。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Patients with refractory chronic cough (RCC) are being seen in increasing numbers within otolaryngology clinics. Identifying the next steps in the evaluation and management of cough in patients who have had first-line treatment for gastroesophageal reflux, sinonasal disease, pulmonary disease, and angiotensin-converting enzyme inhibitor-related cough is paramount. This state-of-the-art review focuses on emerging treatments for RCC from an otolaryngology perspective. DATA SOURCES: Pubmed. REVIEW METHODS: The available literature on chronic cough, with a focus on RCC, emerging paradigms concerning pathophysiology, and evolving treatment approaches was reviewed and summarized. CONCLUSIONS: Guided by a more detailed understanding of refractory cough physiology, a myriad of new treatment options have been developed to treat RCC. These are primarily aimed at disrupting what is thought to be a hypersensitive cough reflex, whether by a dampening of its sensory inputs or an alteration in motor activity, and are inclusive of neuromodulator treatments, superior laryngeal nerve blockade, vocal fold augmentation, botulinum toxin injection, topical capsaicin, and potentially the eventual use of P2X3 antagonists. Improved laryngopharyngeal reflux diagnosis and management, as well as the potential benefit of behavioral cough suppression therapy, are also discussed. IMPLICATIONS FOR PRACTICE: The literature supporting each of these strategies is growing-and as more patients with RCC seek otolaryngology care, knowledge of these various approaches may improve the overall treatment of this condition.

来源:Otolaryngol Head Neck Surg,查看原文。版权归原作者所有。

引用

  1. Lilly GL, Carroll T, Pietsch K, et al. Refractory Chronic Cough: A State-of-the-Art Review for Otolaryngologists. Otolaryngol Head Neck Surg. 2024. PMID: 39575647. doi:10.1002/ohn.1019

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。